Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1987 2
1988 1
1989 1
1990 3
1991 3
1992 4
1993 2
1994 1
1995 1
1996 2
1997 3
1998 3
1999 5
2000 9
2001 9
2002 9
2003 12
2004 20
2005 12
2006 15
2007 13
2008 21
2009 12
2010 22
2011 17
2012 21
2013 12
2014 24
2015 27
2016 20
2017 27
2018 25
2019 25
2020 26
2021 26
2022 20
2023 18
2024 30
2025 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for lerouge
Search for Lerou E instead (1 results)
Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.
Barry PJ, Mall MA, Álvarez A, Colombo C, de Winter-de Groot KM, Fajac I, McBennett KA, McKone EF, Ramsey BW, Sutharsan S, Taylor-Cousar JL, Tullis E, Ahluwalia N, Jun LS, Moskowitz SM, Prieto-Centurion V, Tian S, Waltz D, Xuan F, Zhang Y, Rowe SM, Polineni D; VX18-445-104 Study Group. Barry PJ, et al. N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665. N Engl J Med. 2021. PMID: 34437784 Free PMC article. Clinical Trial.
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Le Pechoux C, Pourel N, Barlesi F, Lerouge D, Antoni D, Lamezec B, Nestle U, Boisselier P, Dansin E, Paumier A, Peignaux K, Thillays F, Zalcman G, Madelaine J, Pichon E, Larrouy A, Lavole A, Argo-Leignel D, Derollez M, Faivre-Finn C, Hatton MQ, Riesterer O, Bouvier-Morel E, Dunant A, Edwards JG, Thomas PA, Mercier O, Bardet A. Le Pechoux C, et al. Lancet Oncol. 2022 Jan;23(1):104-114. doi: 10.1016/S1470-2045(21)00606-9. Epub 2021 Dec 15. Lancet Oncol. 2022. PMID: 34919827 Clinical Trial.
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.
Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP. Karlsen TH, et al. Lancet. 2022 Jan 1;399(10319):61-116. doi: 10.1016/S0140-6736(21)01701-3. Epub 2021 Dec 2. Lancet. 2022. PMID: 34863359 Free article. Review. No abstract available.
Biomaterials for enhanced immunotherapy.
Cunningham N, Lapointe R, Lerouge S. Cunningham N, et al. APL Bioeng. 2022 Dec 16;6(4):041502. doi: 10.1063/5.0125692. eCollection 2022 Dec. APL Bioeng. 2022. PMID: 36561511 Free PMC article. Review.
AFSOS-SFRO Guidelines on Radiation-Induced Lung Injury.
Cravereau O, Bourbonne V, Vaugier L, Lucia F, Tinier FL, Cadranel J, Duchemann B, Habert P, Martz N, Gehin W, Bruand M, Stefani A, Marcel J, Trampetti I, Clement-Duchene C, Lerouge D, Laville A, Cao K, Pourel N, Zaccariotto A, Belliere-Calendry A, Thillays F, Tanguy R, Antoni D, Girard N, Martin E, Godbert B, Nakad A, Treffel G, Massin M, Charzat V, Thureau S, Lapierre A, Faivre JC. Cravereau O, et al. Clin Lung Cancer. 2025 Jul 17:S1525-7304(25)00152-4. doi: 10.1016/j.cllc.2025.07.008. Online ahead of print. Clin Lung Cancer. 2025. PMID: 40796462 Review.
Radiotherapy for primary lung cancer.
Khalifa J, Lerouge D, Le Péchoux C, Pourel N, Darréon J, Mornex F, Giraud P. Khalifa J, et al. Cancer Radiother. 2022 Feb-Apr;26(1-2):231-243. doi: 10.1016/j.canrad.2021.11.005. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953709
[Stereotaxic radiotherapy of primary extracranial tumors].
Giraud P, Lerouge D, Latorzeff I, Mirabel X, Dohan A, Mordant P, Barry de Longchamps N. Giraud P, et al. Cancer Radiother. 2020 Oct;24(6-7):513-522. doi: 10.1016/j.canrad.2020.06.020. Epub 2020 Aug 20. Cancer Radiother. 2020. PMID: 32830055 Review. French.
Status of Sepsis Care in European Hospitals: Results from an International Cross-Sectional Survey.
Scheer CS, Giamarellos-Bourboulis EJ, Ferrer R, Idelevich EA, Annane D, Artigas A, Aslan AT, Bottari G, Bouma HR, Černý V, Curić Radivojević R, Dakou K, Dewitte K, Elbahnasawy M, Gründling M, Gurjar M, Hästbacka J, Kyprianou M, Laribi S, Lassen A, Lebedinskii K, Máca J, Malbrain MLNG, Monti G, Ostermann M, Osthoff M, Paiva JA, Sabbatucci M, Śmiechowicz J, Ştefan MG, Vollmer M, Vuković N, Zaragkoulias K, Reinhart K, Linder A, Filipescu D; European Sepsis Care Study Group. Scheer CS, et al. Am J Respir Crit Care Med. 2025 Apr;211(4):587-599. doi: 10.1164/rccm.202406-1167OC. Am J Respir Crit Care Med. 2025. PMID: 39787606 Free PMC article.
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.
Vera P, Thureau S, Le Tinier F, Chaumet-Riffaud P, Hapdey S, Kolesnikov-Gauthier H, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boissellier P, Guillemard S, Salem N, Brenot-Rossi I, Le Péchoux C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Moisson P, Larrouy A, Modzelewski R, Gouel P, Ghazzar N, Langlais A, Amour E, Zalcman G, Giraud P. Vera P, et al. Lancet Oncol. 2024 Sep;25(9):1176-1187. doi: 10.1016/S1470-2045(24)00320-6. Epub 2024 Aug 9. Lancet Oncol. 2024. PMID: 39134086 Clinical Trial.
Radiotherapy in the management of lung oligometastases.
Bourbonne V, Lévy A, Khalifa J, Antoni D, Blais E, Darréon J, Le Péchoux C, Lerouge D, Giraud P, Marguerit A, Pourel N, Riet FG, Thureau S. Bourbonne V, et al. Cancer Radiother. 2024 Feb;28(1):36-48. doi: 10.1016/j.canrad.2023.06.030. Epub 2024 Jan 16. Cancer Radiother. 2024. PMID: 38228422 Review.
467 results